Neogen Corporation Debt Securities, Trading, Amortized Cost
Neogen Corporation (NEOG) had Debt Securities, Trading, Amortized Cost of $325.00 thousand as of 2024-05-31, per its 10-K filed 2024-07-30.
Discontinued › Notes
us-gaap:TradingSecuritiesDebtAmortizedCost · last filed 2024-07-30
- 2024-05-31: Debt Securities, Trading, Amortized Cost $325.00K.
- 2023-05-31: Debt Securities, Trading, Amortized Cost $83.55M.
- 2022-05-31: Debt Securities, Trading, Amortized Cost $339.54M.
- 2022-02-28: Debt Securities, Trading, Amortized Cost $337.41M.
| Period end | Debt Securities, Trading, Amortized Cost |
|---|---|
| 2024-05-31 | $325.00K 10-K · filed 2024-07-30 |
| 2023-05-31 | $83.55M 10-K · filed 2024-07-30 |
| 2022-05-31 | $339.54M 10-K · filed 2022-07-27 |
| 2022-02-28 | $337.41M 10-Q · filed 2022-04-01 |
| 2021-11-30 | $338.69M 10-Q · filed 2021-12-30 |
| 2021-08-31 | $329.66M 10-Q · filed 2021-09-30 |
| 2021-05-31 | $305.28M 10-K · filed 2022-07-27 |
| 2021-02-28 | $279.88M 10-Q · filed 2021-03-31 |
| 2020-11-30 | $276.63M 10-Q · filed 2020-12-29 |
| 2020-08-31 | $305.62M 10-Q · filed 2020-09-30 |
| 2020-05-31 | $276.85M 10-K · filed 2021-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |